12-55703032-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002206.3(ITGA7):​c.334+19A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.53 in 1,613,676 control chromosomes in the GnomAD database, including 235,371 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 20973 hom., cov: 33)
Exomes 𝑓: 0.53 ( 214398 hom. )

Consequence

ITGA7
NM_002206.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.642

Publications

13 publications found
Variant links:
Genes affected
ITGA7 (HGNC:6143): (integrin subunit alpha 7) The protein encoded by this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. They mediate a wide spectrum of cell-cell and cell-matrix interactions, and thus play a role in cell migration, morphologic development, differentiation, and metastasis. This protein functions as a receptor for the basement membrane protein laminin-1. It is mainly expressed in skeletal and cardiac muscles and may be involved in differentiation and migration processes during myogenesis. Defects in this gene are associated with congenital myopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2009]
ITGA7 Gene-Disease associations (from GenCC):
  • congenital muscular dystrophy due to integrin alpha-7 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 12-55703032-T-C is Benign according to our data. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55703032-T-C is described in CliVar as Benign. Clinvar id is 94044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA7NM_002206.3 linkc.334+19A>G intron_variant Intron 2 of 24 ENST00000257879.11 NP_002197.2 Q13683-7Q4LE35

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA7ENST00000257879.11 linkc.334+19A>G intron_variant Intron 2 of 24 1 NM_002206.3 ENSP00000257879.7 Q13683-7

Frequencies

GnomAD3 genomes
AF:
0.510
AC:
77558
AN:
151962
Hom.:
20959
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.364
Gnomad AMI
AF:
0.573
Gnomad AMR
AF:
0.605
Gnomad ASJ
AF:
0.475
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.719
Gnomad FIN
AF:
0.651
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.490
GnomAD2 exomes
AF:
0.596
AC:
149770
AN:
251112
AF XY:
0.597
show subpopulations
Gnomad AFR exome
AF:
0.362
Gnomad AMR exome
AF:
0.716
Gnomad ASJ exome
AF:
0.474
Gnomad EAS exome
AF:
0.939
Gnomad FIN exome
AF:
0.650
Gnomad NFE exome
AF:
0.513
Gnomad OTH exome
AF:
0.553
GnomAD4 exome
AF:
0.532
AC:
777442
AN:
1461596
Hom.:
214398
Cov.:
57
AF XY:
0.537
AC XY:
390214
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.353
AC:
11815
AN:
33476
American (AMR)
AF:
0.703
AC:
31446
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.480
AC:
12535
AN:
26136
East Asian (EAS)
AF:
0.936
AC:
37145
AN:
39700
South Asian (SAS)
AF:
0.696
AC:
60020
AN:
86254
European-Finnish (FIN)
AF:
0.641
AC:
34125
AN:
53204
Middle Eastern (MID)
AF:
0.501
AC:
2890
AN:
5768
European-Non Finnish (NFE)
AF:
0.499
AC:
555248
AN:
1111944
Other (OTH)
AF:
0.533
AC:
32218
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
22049
44099
66148
88198
110247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16230
32460
48690
64920
81150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.510
AC:
77605
AN:
152080
Hom.:
20973
Cov.:
33
AF XY:
0.524
AC XY:
38956
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.364
AC:
15117
AN:
41500
American (AMR)
AF:
0.606
AC:
9256
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.475
AC:
1647
AN:
3470
East Asian (EAS)
AF:
0.935
AC:
4804
AN:
5136
South Asian (SAS)
AF:
0.717
AC:
3465
AN:
4832
European-Finnish (FIN)
AF:
0.651
AC:
6892
AN:
10580
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.511
AC:
34716
AN:
67962
Other (OTH)
AF:
0.494
AC:
1044
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1861
3721
5582
7442
9303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.433
Hom.:
2626
Bravo
AF:
0.497
Asia WGS
AF:
0.768
AC:
2668
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 18, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital muscular dystrophy due to integrin alpha-7 deficiency Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
3.6
DANN
Benign
0.37
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293413; hg19: chr12-56096816; API